Importantly, neither of these studies investigated the long-term effects of stroke on α-synuclein aggregation, the appearance of pathologic α-synuclein in non-ischemic brain regions, nor did they report any loss of dopaminergic neurons or subsequent motor disease in ischemic animals. Here, SNCA is linked to stroke disorder.